Browsing by Author Yllescas, María
Showing results 1 to 3 of 3
| Issue Date | Title | Author(s) |
|---|---|---|
| 11-Oct-2016 | Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study | Troya, Jesús; Ryan, Pablo; Ribera, Esteban; Podzamczer Palter, Daniel; Hontanon, Victor; Terrón, Jose Alberto; Boix, Vicente; Moreno Guillén, Santiago; Barrufet, Pilar M.; Castaño, Manuel A.; Carrero, Ana; Galindo, María José; Suárez Lozano, Ignacio; Knobel Freud, Hernando Javier; Raffo, Miguel; Solís, Javier; Yllescas, María; Esteban, Herminia; González Garcia, Juan; Berenguer, Juan; Imaz, Arkaitz; GESIDA-8314 Study Group |
| 25-Feb-2021 | Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score. | Berenguer, J. (Joaquín Berenguer Lapuerta); Borobia, Alberto M.; Ryan, Pablo; Rodríguez Baño, Jesús; Bellón, José M.; Jarrín Vera, Inmaculada; Carratalà, Jordi; Pachón, Jerónimo; Carcas Sansuán, Antonio J.; Yllescas, María; Arribas, José Ramón; Smithson Amat, Alejandro; COVID-19 Spain Study Group; COVID HULP Study Group |
| 1-Feb-2021 | Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19) | Rodríguez Baño, Jesús; Pachón, Jerónimo; Carratalà, Jordi; Ryan, Pablo; Jarrín, Inmaculada; Yllescas, María; Arribas, José Ramón; Berenguer, Juan; SAM-COVID Study Group |